Related Experiment Video
Updated: Jan 4, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Cancer Nanomedicines Based on Synthetic Polypeptides
Huanli Sun1, Xiaolei Gu1, Qiang Zhang1
1Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and Protection , Soochow University , Suzhou 215123 , China.
Synthetic polypeptide nanomedicines offer a promising, safe, and effective approach for cancer therapy. These advanced formulations improve drug delivery and enhance anticancer efficacy, paving the way for future clinical applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Nanomedicines are crucial for treating malignant cancers.
- Synthetic polypeptide nanomedicines offer safety, structural advantages, and versatile drug delivery capabilities for diverse therapeutic agents.
- Several polypeptide-based nanoformulations are in clinical trials for solid tumors.
Purpose of the Study:
- To review the latest advancements in the design and fabrication of cancer nanomedicines utilizing synthetic polypeptides.
- To discuss the potential of these nanomedicines in targeted cancer therapy.
- To highlight challenges associated with their clinical translation.
Main Methods:
- Review of current literature on synthetic polypeptide nanomedicines.
- Analysis of design principles for enhanced drug loading, tumor targeting, and stimuli-responsiveness.
- Examination of virus-mimicking polypeptide vehicles for biotherapy.
Main Results:
- Development of robust, high drug-loading polypeptide nanomedicines with improved safety and efficacy.
- Creation of tumor-targeting, stimuli-sensitive, and membrane-disrupting nanomedicines.
- Emergence of virus-mimicking polypeptide vehicles for efficient nonviral delivery of biologics.
Conclusions:
- Synthetic polypeptide nanomedicines represent a significant advancement in cancer treatment, offering improved safety and efficacy.
- Further development is needed to address challenges in clinical translation for targeted cancer therapy.
- These nanomedicines hold great promise for the future of cancer biotherapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

